CarpentieriUHaggMELockhartLHGustavsonLPBoxQTWestEF. Clinical experience in prevention of candidiasis by nystatin in children with acute lymphocytic leukemia. J Pediatr1978; 92: 593–5.
2.
PizzutoJConteGAmbrizRAvilesAMoralesM. Nystatin prophylaxis in leukemia and lymphoma. N Engl J Med1978; 298: 279–80.
3.
DegregorioMWLeeMWFRiesCA. Candida infections in patients with acute leukemia: ineffectiveness of nystatin prophylaxis and relationship between oropharyngeal and systemic candidiasis. Cancer1982; 50: 2780–4.
4.
BarrettAP. Evaluation of nystatin in prevention and elimination of oropharyngeal Candida in immunosuppressed patients. Oral Surg Oral Med Oral Pathol1984; 58: 148–51.
5.
BuchananAGRibenPDRaynerENParkerSERonaldARLouieTJ. Nystatin prophylaxis of fungal colonization and infection in granulocytopenic patients: correlation of colonization and clinical outcome. Clin Invest Med1985; 8: 139–47.
6.
WilliamsCWhitehouseJMAListerTAWrigleyPFM. Oral anticandidal prophylaxis in patients undergoing chemotherapy for acute leukemia. Med Pediatr Oncol1977; 3: 275–80.
7.
MeunierF. Prevention of mycoses in immunocompromised patients. Rev Infect Dis1987; 9: 408–16.
8.
DenningDWDonnellyJPHellreigelKPItoJMartinoPvan't WoutJW. Antifungal prophylaxis during neutropenia or allogenic bone marrow transplantation: what is the state of the art?Chemotherapy1992; 38 (suppl): S43–9.
